Wall Street Brunch: Here Come The 13Fs

This week, hedge funds are submitting 13F filings, with investors keenly observing "smart money" positioning for insights into recent market highs, Fed rate cut expectations, and tech/AI valuations, exemplified by Michael Burry's disclosed shorts against Nvidia and Palantir. Q3 earnings season is winding down, showing 82% of S&P 500 companies beating profit estimates but with cautious forward guidance, making Walt Disney's upcoming fiscal Q4 report a key focus. Concurrently, a prolonged government shutdown is anticipated until late November, and former President Trump's proposals to redirect ACA funds and use tariffs for direct payments are gaining attention.

Analysis

The upcoming 13F filings are a key focus, with investors scrutinizing "smart money" positioning for insights into Q3 market activity. Michael Burry's disclosed short positions against AI darlings Nvidia (NVDA) and Palantir (PLTR) signal potential caution regarding stretched valuations in the tech and AI sectors. These filings will reveal whether funds aggressively bought during Q3's market highs or maintained a cautious stance amid rate cut expectations.

Q3 earnings season is concluding, with 82% of S&P 500 companies beating profit estimates and 77% exceeding revenue expectations, indicating robust past performance. However, forward guidance is notably cautious, with 42 S&P names issuing negative profit outlooks versus 31 raising forecasts. Walt Disney (DIS) is a critical upcoming report, with investor focus on fiscal Q4 guidance, debt reduction, and the ABC/ESPN-YouTube standoff.

Macroeconomic uncertainty is heightened by an anticipated government shutdown lasting until at least November 20th, potentially impacting market sentiment. Politically, former President Trump's proposals to redirect ACA funds and use tariff revenues for direct payments could introduce significant policy shifts, though his favorable ruling odds on tariffs have declined to 20%. In M&A, Novo Nordisk (NVO) abandoned Metsera (MTSR), while Pfizer (PFE) cemented a $10 billion deal, signaling continued healthcare sector activity.

Key Decisions for Investors

• Closely monitor upcoming 13F filings for insights into institutional positioning, particularly regarding tech and AI exposures and any divergence from recent market trends.
• Exercise caution on forward guidance despite strong Q3 earnings beats, as the prevalence of negative outlooks suggests potential headwinds for future corporate profitability.
• Pay close attention to Walt Disney's (DIS) earnings call for cues on debt management, dividend/buyback policy, and resolution of content distribution disputes, which could significantly impact its valuation.
• Factor in the prolonged government shutdown and evolving political proposals, including potential healthcare and tariff policy shifts, as these introduce significant macro and sector-specific risks.